Profile
| Metric | Value |
|---|---|
| Full Name | Alvotech |
| Ticker | NASDAQ: ALVOW |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Luxembourg |
| IPO | |
| Indexes | Not included |
| Website | alvotech.com |
| Employees | 1,012 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.51 | |
| Price, 1D Change | 0.00% | |
| Market Cap | $153M | |
| - | ||
| PE Ratio | - | |
| Beta | 2.32 | |
| Revenue | $490M | |
| Revenue, 1Y Change | +435.56% | |
| - | ||
| EPS, 1Y Change | - |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| - | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| Revenue | $489.68M | |
| Revenue Estimate | N/A | $582.88M |
| Revenue Est. Change | N/A | +19.03% |
| Current Price | $0.51 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
No EPS data available
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $454.43M | $489.68M | +7.76% | |
| $582.88M | N/A | +19.03% | |
| $842.22M | N/A | +71.99% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -84.30% | |
| Price, 3Y | -66.88% | |
| Market Cap, 1Y | - | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +435.56% | |
| Revenue, 3Y | +1,231.67% | |
| - | ||
| - |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.51 | |
| SMA 200 | $1.60 | |
| SMA 200 vs Price | +213.61% | |
| SMA 50 | $1.06 | |
| SMA 50 vs Price | +107.41% | |
| Beta | 2.32 | |
| ATR | $0.17 | |
| 14-Day RSI | 41.63 | |
| 10-Day Volatility | 301.00% | |
| 1-Year Volatility | 224.04% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| Payout Ratio | - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $489.68M | |
| - | ||
| Gross Profit | $304.37M | |
| Gross Margin | 62.16% | |
| Operating Profit | $69.64M | |
| Operating Margin | 14.22% | |
| Net Income | -$231.86M | |
| - | ||
| EBITDA | $101.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -2.88 | |
| Current Ratio | 2.35 | |
| Quick Ratio | 1.69 | |
| Interest Coverage | -0.41 | |
| - | ||
| Altman Z-Score | -2.25 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 0.27 | |
| PB Ratio | -0.61 | |
| EV/EBITDA | 8.11 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$444.72M | |
| Cash & Equivalents | $51.43M | |
| Total Assets | $1.22B | |
| Current Assets | $455.02M | |
| Total Liabilities | $1.63B | |
| Current Liabilities | $193.40M | |
| Total Debt | $1.19B | |
| Short Term Debt | $32.70M | |
| Accounts Payable | $67.13M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $420.04M | |
| Operating Expenses | $234.73M | |
| Cost Of Goods Sold | $185.31M | |
| SG&A | $61.45M | |
| D&A | $31.30M | |
| Interest Expense | $153.99M | |
| Income Tax | $14.30M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$236.84M | |
| CFI | -$18.87M | |
| CFF | $297.31M | |
| Capex | $57.00M | |
| Free Cash Flow | -$293.84M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Deutsche Bank |
Analyst sentiment
Institutional ownership
Screeners with ALVOW
FAQ
What is the ticker symbol for Alvotech?
The ticker symbol for Alvotech is NASDAQ:ALVOW
Does Alvotech pay dividends?
No, Alvotech does not pay dividends
What sector is Alvotech in?
Alvotech is in the Healthcare sector
What industry is Alvotech in?
Alvotech is in the Specialty & Generic Drug Manufacturers industry
What country is Alvotech based in?
Alvotech is headquartered in Luxembourg
When did Alvotech go public?
Alvotech initial public offering (IPO) was on June 16, 2022
Is Alvotech in the S&P 500?
No, Alvotech is not included in the S&P 500 index
Is Alvotech in the NASDAQ 100?
No, Alvotech is not included in the NASDAQ 100 index
Is Alvotech in the Dow Jones?
No, Alvotech is not included in the Dow Jones index
When does Alvotech report earnings?
The date for Alvotech's next earnings report has not been announced yet
Data Sources & References
- ALVOW Official Website www.alvotech.com
- ALVOW Profile on Yahoo Finance finance.yahoo.com/quote/ALVOW
- ALVOW Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alvow